This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

FDA’s Draft Guidance for New Dietary Ingredient (NDI) Notifications in Dietary Supplements: Counting the Cost

1/28 Next

SupplySide Central, a feature stage located amidst the busy exhibit hall of SupplySide West in Las Vegas, was abuzz with premium educational speakers Oct. 6 and 7. One session drawing a great deal of interest was Friday afternoon’s “Counting the Cost of FDA’s Draft Guidance,” featuring Loren Israelsen of the United Natural Products Alliance (UNPA) and Skye Lininger, DC, of Healthnotes Inc.

FDA released its updated draft guidance on new dietary ingredients (NDIs) in August, and industry is determining how the notification process will affect business. The session shared insights into the number and type of dietary supplements and dietary ingredients currently being sold in the U.S. market and what it could mean for cost of implementation to industry.

Editor’s Note: FDA has extended the NDI draft guidance comment period to Dec. 12, 2016.

comments powered by Disqus